Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Alzheimer Disease

A 19-year-old is the youngest person to be diagnosed with Alzheimer's disease – the cause is a mystery

A 19-year-old man from China, who has been having memory problems since the age of 17, was diagnosed with dementia, according to a recent case study published in the Journal of Alzheimer’s Disease.

The Conversation

What is frontotemporal degeneration?

Frontotemporal degeneration (FTD) is a group of neurologic disorders associated with changes in personality, behavior, language or movement. Some FTD forms are inherited, and some are not. Typically, people develop FTD symptoms before age 60.

Tribune News Service

Researchers find similar brain pattern shifts in two common conditions

A new study finds changes in the brain associated with obesity overlap with similar patterns seen in Alzheimer's disease.

Inverse

From analysis to the latest developments in health,
read the most diverse news in one place.

Study: Weight Loss Can Be Early Predictor Of Alzheimer's Disease In People With Down Syndrome

Researchers revealed that unintentional weight loss in individuals with Down syndrome may signal the beginning of Alzheimer's disease long before usual cognitive symptoms like memory loss and dementia become apparent. Read further on Dynamite News:

Dynamite News

Viruses can speed up unhealthy brain aging — vaccines may offer peace of mind

There is currently no cure for dementia, but getting vaccinated for common viral illnesses may reduce your risk.

Inverse

New blood test could predict Alzheimer’s 3.5 years before disease

Researchers say the test could help ‘predict onset of disease early in a non-invasive fashion’

Evening Standard

New blood test could detect Alzheimer’s disease years before diagnosis

Research supports idea that components in human blood can influence formation of new brain cells

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

New blood test could detect Alzheimer’s disease 3.5 years before diagnosis – study

Research supports idea that components in human blood can influence formation of new brain cells

The Independent UK

New test 'could detect Alzheimer’s disease 3.5 years before diagnosis'

Researchers establish a blood-based test that could predict risk of the condition at an earlier stage

Wales Online

New test could detect Alzheimer’s disease 3.5 years before diagnosis – study

The research supports the idea that components in human blood can influence the formation of new brain cells.

The Independent UK

Possible link between Alzheimer's disease and gut microbiome found in mice – new study

Researchers may have found an unlikely contributor to the development of Alzheimer’s disease: the bacteria in your gut. Their study, published in the journal Science, suggested that certain gut bacteria increase the brain damage seen in mice with an Alzheimer’s-like disease.

The Conversation

Alzheimer's: blood biomarker may help identify the disease ten years before symptoms start

Though Alzheimer’s disease affects more than 55 million people worldwide, there’s still no cure for the condition – and treatment options are limited.

The Conversation

Vaccination to prevent dementia? New research suggests one way viral infections can accelerate neurodegeneration

One in nine Americans ages 65 and over had Alzheimer’s disease in 2022, and countless others were indirectly affected as caregivers, health care providers and taxpayers. There is currently no cure – available treatments primarily focus on prevention by encouraging protective factors, such as exercise and healthy diet, and reducing…

The Conversation

HRT ‘potentially important’ in reducing women’s dementia risk

Research suggests hormone replacement therapy may reduce risk of Alzheimer’s in some women

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

Tribune News Service

Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.

Dynamite News

New Biomarker Test Can Identify Alzheimer's Neurodegeneration In Blood: Study

A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration. Read on for details:

The Independent UK

New blood test developed to detect signs of Alzheimer’s disease

‘A blood test is cheaper, safer and easier to administer, and it can improve clinical confidence in diagnosing Alzheimer’s’

Get all your
news in one place.

100's of premium titles.
One news app.

Dynamite News

Traumatic Brain Injury, PTSD Associated With Alzheimer's: Research

The medical profession has never before investigated the effects of traumatic brain injury (TBI), post-traumatic stress disorder (PTSD) and genetic risk factors in a sizable cohort. Read on for details:

ABC News

Researchers find signs of Alzheimer's disease in dolphins

Researchers in Scotland have found dolphins with classic markers of Alzheimer's disease in their brains, potentially pointing to the reason the animals became stranded.

The Conversation

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

On Nov. 30, Eisai and Biogen announced the results of their latest phase 3 clinical trial in Alzheimer’s disease. The verdict: an 18-month treatment with lecanemab slows functional and cognitive loss by 27 per cent in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. The study…

The Guardian - UK

Dolphins may suffer from Alzheimer’s disease, say researchers in Scotland

Bottlenose dolphin, a long-finned pilot whale and a third species found to have markers of the degenerative disease

The Independent UK

Stranded dolphins’ brains show common signs of Alzheimer’s disease – study

The findings might help explain why some species get stranded, researchers say.

The Independent UK

Dolphins may suffer brain damage similar to Alzheimer’s disease

A new study shows four animals from different dolphin species have some of the brain changes associated with human Alzheimer’s disease

The Conversation

Why does the Alzheimer's brain become insulin-resistant?

As the population ages, the number of people with neurodegenerative diseases, such as Alzheimer’s disease, increases. Approximately 75,000 Canadians are diagnosed with Alzheimer’s disease each year and experience a decline in their cognitive abilities. The ordeal usually lasts for several years while their family members watch helplessly.

1 … 11 12 13 14

People

Down

102 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

353 stories

Biogen

218 stories

University of Edinburgh

206 stories

University of Glasgow

157 stories

Biobank

146 stories

National Institutes of Health

86 stories

Eisai

84 stories

New England Journal of Medicine

32 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.